Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa in high-NTX NSCLC with bone metastasis
NCT00762346Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2008
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in bone metastases, sponsored by Sun Yat-sen University. Started Sep 2008; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00762346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762346.